Yufang Cao

Yufang Cao

Auto-generated profile, based on publicly available information

Yufang Cao

Key Laboratory of Study and Discovery of Small Targeted Molecules of Hunan Province Key Laboratory of Protein Chemistry and Developmental Biology of Fish of Ministry of Education Department of Pharmacy School of Medicine Hunan Normal University Changsha, Hunan China

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2022 in ChemistrySelect
Verified
Journal Article
Open access
PDF file
YCYufang Cao
Yufang Cao
SXSimeng Xu
Simeng Xu
CXCangcang Xu
Cangcang Xu
DXDi Xiao
Di Xiao
ZCZhuliang Chen
Zhuliang Chen
XYXiaoping Yang
Xiaoping Yang
Phenformin has been recognized as a drug with anti‐ proliferative potential. Due to its excellent pharmaceutical parameters, its structure was modified based on the principle of intermediate derivatization, and the influence of different substituents of phenformin and its position on the benzene ring on its antiproliferative activity was discussed. In this study, 15 phenformin derivatives with different substituents were synthesized by inserting electron‐withdrawing or electron‐donating groups on the different positions of phenyl side of phenformin, and screened for their antiproliferative activities. It was found that the introduction of electron‐donating substituents slightly improves the antiproliferative activity of phenformin, however, the introduction of −Cl and −OCF 3 substituents significantly increased the antiproliferative activity of phenformin with N‐l‐(2‐chloro) phenethylbiguanide ( 2B ), the best antiproliferative activity compound. Western blot assay and the molecular docking studies demonstrated that 2B activates AMPK.